The IASLC 2027 Targeted Therapies of Lung Cancer (TTLC) Meeting returns to Huntington Beach, California, bringing together the global thoracic oncology community to advance the future of precision medicine.

Designed for researchers, clinicians, and industry leaders, TTLC 2027 will showcase the latest advances in targeted therapies for thoracic malignancies, including emerging molecular targets, innovative treatment strategies, and early clinical trial findings. Through expert-led presentations, interactive discussions, and valuable networking opportunities, attendees will have the chance to exchange ideas, foster collaborations, and gain insights that will help shape the next generation of lung cancer care.

We look forward to welcoming you to Huntington Beach in February 2027!